← ANALYST RATINGS · TIPRANKS
Idexx Laboratories (IDXX): analyst forecast and price target
Analyst consensus
Moderate Buy5 Buy2 Hold0 Sell
Ratings of 7 analysts in the last 3 months · top analysts only12-month forecast
Based on 7 price targets given in the last 3 months, the average target is $712, the highest $805, the lowest $665. The average is +27.2% from the last price of $560.
Analyst ratings 15
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Chris Schott★★★★★★★★★★#1915 · hits 58% · avg +5.7% | J.P. Morgan | $775 → $750−3.2% | Buy | +33.8% | Assigned | 16.10.26on TipRanks 07:45 | +3.5% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $588 → $591+0.5% | Buy | +5.5% | Reiterated | 15.10.26on TipRanks Oct 14 23:06 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $596 → $598+0.3% | Buy | +6.7% | Reiterated | 15.10.26on TipRanks Oct 14 23:06 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $583 → $585+0.3% | Buy | +4.4% | Reiterated | 15.10.26on TipRanks Oct 14 23:06 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $570 → $572+0.4% | Buy | +2.1% | Upgrade | 15.10.26on TipRanks Oct 14 23:06 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $593 → $596+0.5% | Buy | +6.4% | Reiterated | 15.10.26on TipRanks Oct 14 23:06 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $582 → $588+1.0% | Buy | +4.9% | Reiterated | 13.10.26on TipRanks Oct 12 23:06 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $590 → $596+1.0% | Buy | +6.4% | Reiterated | 13.10.26on TipRanks Oct 12 23:06 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $577 → $583+1.0% | Buy | +4.0% | Reiterated | 13.10.26on TipRanks Oct 12 23:06 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $564 → $570+1.1% | Buy | +1.7% | Upgrade | 13.10.26on TipRanks Oct 12 23:06 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $588 → $593+0.9% | Buy | +5.8% | Reiterated | 13.10.26on TipRanks Oct 12 23:06 | — | |
| Scott Schoenhaus★★★★★★★★★★#12104 · hits 35% · avg −9.7% | KeyBanc | — | Hold | — | Initiated | 12.10.26on TipRanks 04:55 | +1.2%next day −0.7% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $575 → $582+1.2% | Buy | +3.9% | Reiterated | 11.10.26on TipRanks Oct 10 23:06 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $583 → $590+1.2% | Buy | +5.3% | Reiterated | 11.10.26on TipRanks Oct 10 23:06 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $570 → $577+1.2% | Buy | +3.0% | Reiterated | 11.10.26on TipRanks Oct 10 23:06 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $557 → $564+1.3% | Buy | +0.6% | Upgrade | 11.10.26on TipRanks Oct 10 23:06 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $580 → $588+1.4% | Buy | +4.9% | Reiterated | 11.10.26on TipRanks Oct 10 23:06 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $598 → $575−3.8% | Buy | +2.6% | Reiterated | 09.10.26on TipRanks Oct 8 23:06 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $606 → $583−3.8% | Buy | +4.0% | Reiterated | 09.10.26on TipRanks Oct 8 23:06 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $593 → $570−3.9% | Buy | +1.7% | Reiterated | 09.10.26on TipRanks Oct 8 23:06 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $580 → $557−4.0% | Buy | −0.6% | Upgrade | 09.10.26on TipRanks Oct 8 23:06 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $603 → $580−3.8% | Buy | +3.5% | Reiterated | 09.10.26on TipRanks Oct 8 23:06 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $588 → $598+1.7% | Buy | +6.7% | Reiterated | 07.10.26on TipRanks Oct 6 23:06 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $596 → $606+1.7% | Buy | +8.1% | Reiterated | 07.10.26on TipRanks Oct 6 23:06 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $583 → $593+1.7% | Buy | +5.8% | Reiterated | 07.10.26on TipRanks Oct 6 23:06 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $570 → $580+1.8% | Buy | +3.5% | Upgrade | 07.10.26on TipRanks Oct 6 23:06 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $594 → $603+1.5% | Buy | +7.6% | Reiterated | 07.10.26on TipRanks Oct 6 23:06 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $595 → $596+0.2% | Buy | +6.4% | Reiterated | 05.10.26on TipRanks Oct 4 23:06 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $582 → $583+0.2% | Buy | +4.0% | Reiterated | 05.10.26on TipRanks Oct 4 23:06 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $593 → $594+0.2% | Buy | +6.0% | Reiterated | 05.10.26on TipRanks Oct 4 23:06 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $589 → $588−0.2% | Buy | +4.9% | Reiterated | 03.10.26on TipRanks Oct 2 23:06 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $597 → $595−0.3% | Buy | +6.2% | Reiterated | 03.10.26on TipRanks Oct 2 23:06 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $584 → $582−0.3% | Buy | +3.9% | Reiterated | 03.10.26on TipRanks Oct 2 23:06 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $571 → $570−0.2% | Buy | +1.7% | Upgrade | 03.10.26on TipRanks Oct 2 23:06 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $595 → $593−0.3% | Buy | +5.8% | Reiterated | 03.10.26on TipRanks Oct 2 23:06 | — | |
| Ryan Daniels★★★★★★★★★★#2878 · hits 48% · avg +5.8% | William Blair | — | Buy | — | Reiterated | 02.10.26on TipRanks 05:15 | −0.6%next day +1.0% · 5 days −1.2% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $589 | Buy | +5.1% | Reiterated | 29.09.26on TipRanks Sep 28 23:06 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $597 | Buy | +6.5% | Reiterated | 29.09.26on TipRanks Sep 28 23:06 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $584 | Buy | +4.2% | Reiterated | 29.09.26on TipRanks Sep 28 23:06 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $571 | Buy | +1.9% | Upgrade | 29.09.26on TipRanks Sep 28 23:06 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $595 | Buy | +6.2% | Reiterated | 29.09.26on TipRanks Sep 28 23:06 | — | |
| Andrea Alfonso★★★★★★★★★★#2181 · hits 100% · avg +43.2% | UBS | $670 | Hold | +19.6% | Assigned | 16.09.26on TipRanks 07:55 | +1.0%next day −2.5% · 5 days −0.4% | ↗ |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $650 → $637−2.0% | Buy | +13.7% | Reiterated | 20.08.26on TipRanks Aug 19 23:06 | — | |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | $660 → $665+0.8% | Hold | +18.7% | Reiterated | 14.08.26on TipRanks 10:15 | −2.6%next day −0.4% · 5 days +2.5% | ↗ |
| Jonathan Block★★★★★★★★★★#2320 · hits 50% · avg +5.3% | Stifel Nicolaus | $675 | Buy | +20.5% | Reiterated | 14.08.26on TipRanks 07:30 | −2.6%next day −0.4% · 5 days +2.5% | ↗ |
| Ryan Daniels★★★★★★★★★★#2878 · hits 48% · avg +5.8% | William Blair | — | Buy | — | Reiterated | 13.08.26on TipRanks 13:55 | −1.3%next day −2.6% · 5 days −1.8% | ↗ |
| Glen Santangelo★★★★★★★★★★#2956 · hits 52% · avg +4.5% | Barclays | $710 | Buy | +26.7% | Reiterated | 11.08.26on TipRanks 04:45 | −1.2%next day −3.0% · 5 days −5.3% | ↗ |
| Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% | Morgan Stanley | $805 | Buy | +43.7% | Reiterated | 05.08.26on TipRanks 08:44 | −0.4%next day +1.1% · 5 days −2.8% | ↗ |
| Daniel Grosslight★★★★★★★★★★#4007 · hits 47% · avg +3.6% | Citi | $650 → $670+3.1% | Hold | +19.6% | Reiterated | 05.08.26on TipRanks 06:40 | −0.4%next day +1.1% · 5 days −2.8% | ↗ |
| Keith Devas★★★★★★★★★★#11126 · hits 14% · avg −11.8% | Jefferies | $792 | Buy | +41.3% | Reiterated | 06.05.26on TipRanks 11:35 | +1.5%next day −0.9% · 5 days −9.9% | ↗ |
| David Westenberg★★★★★★★★★★#602 · hits 56% · avg +17.3% | Piper Sandler | $775 → $750−3.2% | Hold | +33.8% | Reiterated | 09.02.26on TipRanks 07:01 | −1.2%next day +1.3% · 5 days −0.5% | ↗ |
| Mark Massaro★★★★★★★★★★#2635 · hits 40% · avg +5.7% | BTIG | $830 → $800−3.6% | Buy | +42.8% | Reiterated | 03.02.26on TipRanks Feb 2 21:15 | −0.3%next day +2.1% · 5 days +1.8% | ↗ |
| Chris Schott★★★★★★★★★★#1915 · hits 58% · avg +5.7% | J.P. Morgan | $775 | Buy | +38.3% | Reiterated | 03.11.25on TipRanks Nov 5 08:25 | +14.7%next day +1.1% · 5 days −1.6% | ↗ |
| Daniel Clark★★★★★★★★★★#3492 · hits 65% · avg +17.4% | Leerink Partners | $745 → $785+5.4% | Buy | +40.1% | Reiterated | 03.11.25on TipRanks 15:30 | +14.7%next day +1.1% · 5 days −1.6% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Idexx Laboratories
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $699 at a price of $522 (+33.9%); now: $706 at $560 (+26.1%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 5 | 4 | 5 | 7 | 7 | 7 |
| Hold | 5 | 4 | 3 | 4 | 5 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 02.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $3.72 (from $3.64 to $3.82). Last quarter: $4.27.
Sales
Next quarter’s sales estimate — $1.2B (from $1.2B to $1.2B). Last quarter: $1.2B.
Best top-analyst consensus in the sector · Healthcare
About Idexx Laboratories
- CEO: Michael Erickson
- Employees: 11,000
- One IDEXX Drive, Westbrook, ME, 04092, US
- www.idexx.com
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by in
Data from the stock’s TipRanks forecast page, read 17 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗